Risperdal is an atypical antipsychotic drug for the treatment of bipolar disorder and schizophrenia. However, these types of medications have been associated with causing serious, potentially life-threatening health consequences.
AstraZeneca and Nexium Update
Last year AstraZeneca sold the marketing rights to its over-the-counter (OTC) version of Nexium to Pfizer Inc. due to declining revenues, for $250 million. AstraZeneca will receive royalty payments from Pfizer for the OTC version, as well as...
Bayer Agrees to Pay $74 Million in Cipro “Pay for Delay” Case
Bayer has agreed to pay a $74 million settlement in a case where Plaintiffs alleged the drug maker violated antitrust laws by participating in pay-for-delay activities surrounding its drug, Cipro.
A class-action lawsuit charged Bayer...